Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Abbott will market Orion's calcium sensitizer levosimendan

Feb. 24, 1998

Icos monoclonal antibody enters phase II for hemorrhagic shock

Feb. 19, 1998

New once-daily antihypertensive combination available in U.S.

Feb. 18, 1998

A novel NOS inhibitor possibly involved in elevating arterial pressure

Feb. 18, 1998

rAAV vector to be evaluated for cardiovascular gene transfer

Feb. 17, 1998

KR-30450 exerts cardioprotective effects in ischemic rat hearts

Feb. 16, 1998

Successful results contribute to early termination of phase IIa study of TBC-11251

Feb. 13, 1998

Icos reveals new cGMP-specific PDE inhibitors

Feb. 12, 1998

Antibradycardic M2 receptor antagonists prepared at Yamanouchi

Feb. 11, 1998

Inex acquires antisense assets from Lynx

Feb. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...